BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 8621775)

  • 1. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.
    Belhassen L; Kelly RA; Smith TW; Balligand JL
    J Clin Invest; 1996 Apr; 97(8):1908-15. PubMed ID: 8621775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide.
    Joe EK; Schussheim AE; Longrois D; Mäki T; Kelly RA; Smith TW; Balligand JL
    J Mol Cell Cardiol; 1998 Feb; 30(2):303-15. PubMed ID: 9515007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).
    Georget M; Mateo P; Vandecasteele G; Lipskaia L; Defer N; Hanoune J; Hoerter J; Lugnier C; Fischmeister R
    FASEB J; 2003 Aug; 17(11):1380-91. PubMed ID: 12890691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase.
    Vandecasteele G; Eschenhagen T; Scholz H; Stein B; Verde I; Fischmeister R
    Nat Med; 1999 Mar; 5(3):331-4. PubMed ID: 10086391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis toxin-sensitive G protein but not NO/cGMP pathway mediates the negative inotropic effect of carbachol in adult rat cardiomyocytes.
    Sandirasegarane L; Diamond J
    Pharmacology; 2004 Jan; 70(1):46-56. PubMed ID: 14646356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation.
    Osadchii OE; Woodiwiss AJ; Norton GR
    Pflugers Arch; 2006 May; 452(2):155-63. PubMed ID: 16369769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3.
    Champion HC; Georgakopoulos D; Takimoto E; Isoda T; Wang Y; Kass DA
    Circ Res; 2004 Mar; 94(5):657-63. PubMed ID: 14752030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
    Balligand JL; Kelly RA; Marsden PA; Smith TW; Michel T
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):347-51. PubMed ID: 7678347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y; Karmazyn M
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts.
    Gödecke A; Heinicke T; Kamkin A; Kiseleva I; Strasser RH; Decking UK; Stumpe T; Isenberg G; Schrader J
    J Physiol; 2001 Apr; 532(Pt 1):195-204. PubMed ID: 11368026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes.
    Kanai AJ; Mesaros S; Finkel MS; Oddis CV; Birder LA; Malinski T
    Am J Physiol; 1997 Oct; 273(4):C1371-7. PubMed ID: 9357783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
    Takimoto E; Champion HC; Belardi D; Moslehi J; Mongillo M; Mergia E; Montrose DC; Isoda T; Aufiero K; Zaccolo M; Dostmann WR; Smith CJ; Kass DA
    Circ Res; 2005 Jan; 96(1):100-9. PubMed ID: 15576651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria.
    Muller B; Lugnier C; Stoclet JC
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):444-51. PubMed ID: 1691369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium entry via L-type calcium channels acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes.
    Yu HJ; Ma H; Green RD
    Mol Pharmacol; 1993 Oct; 44(4):689-93. PubMed ID: 7694067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat.
    Bayraktutan U; Yang ZK; Shah AM
    Cardiovasc Res; 1998 Jun; 38(3):719-26. PubMed ID: 9747440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic inhibitory and stimulatory regulation of the L-type Ca2+ current is not altered in cardiac ventricular myocytes from mice lacking endothelial nitric oxide synthase.
    Belevych AE; Harvey RD
    J Physiol; 2000 Oct; 528 Pt 2(Pt 2):279-89. PubMed ID: 11034618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of milrinone on contractility and cyclic adenosine monophosphate production induced by beta1- and beta2-adrenergic receptor activation in human myocardium.
    Carceles MD; Fuentes T; Aroca V; Lopez J; Hernández J
    Clin Ther; 2007 Aug; 29(8):1718-24. PubMed ID: 17919552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.